DaVita
DVA
#2071
Rank
HK$77.44 B
Marketcap
HK$1,158
Share price
-0.15%
Change (1 day)
11.83%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): HK$78.92

According to DaVita's latest financial reports the company's current EPS (TTM) is HK$79.26. In 2024 the company made an earnings per share (EPS) of HK$86.39 an increase over its 2023 EPS that were of HK$59.60.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$78.92-8.64%
2024HK$86.3944.94%
2023HK$59.6027.26%
2022HK$46.84-35.56%
2021HK$72.6844.1%
2020HK$50.4419.7%
2019HK$42.14540.48%
2018HK$6.58-76.07%
2017HK$27.49-19.31%
2016HK$34.07242.52%
2015HK$9.95-62.87%
2014HK$26.7913.43%
2013HK$23.618.45%
2012HK$21.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
HK$183.82 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$82.47 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
HK$115.13 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
HK$14.87-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA